Estazolam

艾司唑仑

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameEstazolam
Drug Alias NameEstazolamum舒樂安定舒乐安定NuctalonEsilgan +[11] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGamma-aminobutyric acid A receptor agonists
TargetsGamma-aminobutyric acid A receptor
Therapy Area/IndicationsAnxiety DisordersSleep Initiation and Maintenance DisordersEpilepsy
Global Approved IndicationsAnxiety DisordersSleep Initiation and Maintenance DisordersEpilepsy
Approved Indications in ChinaAnxiety DisordersSleep Initiation and Maintenance DisordersEpilepsy
Original Approved Country/TerritoryMainland China
Original Approved Date1981/01/01
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesAbbvie Inc
China Registration ClassN/A

Develop Information

Active CompaniesHuazhong Pharmaceutical Co Ltd
Inactive CompaniesAbbott Laboratories
Active IndicationsAnxiety DisordersSleep Initiation and Maintenance DisordersEpilepsy
Inactive IndicationsN/A

Other Information

ATC CodeN05CD04
Related LinksWikipediaDrugBankKEGG